KineMed KineMed Collaborates With Pfizer on Proteomics Biomarkers Building on the companies' existing relationship, the deal licenses KineMed's proteomics platform to the pharmaceuticals giant for CDx development. KineMed, Pronutria Ink R&D Collaboration The partners will use KineMed's proteomics platform to evaluate the effect of biologics developed by Pronutria for metabolic and other diseases. In Brief This Week: Agilent Technologies; Diagnocure; KineMed, Pfizer; PositiveID; SomaLogic NEW YORK (GenomeWeb) – Agilent Technologies said this week that it has mad an adjustment to its second quarter 2014 GAAP net income. KineMed, Pfizer Renew Metabolic Disease Research Collaboration Premium NEW YORK (GenomeWeb News) – KineMed this week announced the renewal of its non-exclusive research collaboration with Pfizer into metabolic disease, and type 2 diabetes in particular. KineMed and CHDI Foundation Extend Collaboration on Huntington's Disease Biomarkers Premium NEW YORK (GenomeWeb News) – KineMed said this week that it has extended its collaboration with the CHDI Foundation on research into biomarkers for Huntington's disease. May 23, 2014 People in the News: Patrick Doyle, Dominique Grau, Jean Halloran Premium May 19, 2014 KineMed, CHDI Foundation Extend Huntington's Disease Collaboration Oct 15, 2013 KineMed Inks Deal with Amgen to Study Brain Proteins Linked to Neurodegenerative Disease Sep 19, 2013 KineMed Wins $225K SBIR Contract to Develop Myocardial Fibrosis Biomarkers Aug 23, 2013 People in the News: Thomas Bachmann, Joseph Eggler, and More Premium May 21, 2013 KineMed, MedImmune Studying Role of Protein Dynamics in Neurodegenerative Diseases Mar 27, 2013 KineMed, Pfizer Renew Research Collaboration Mar 1, 2013 KineMed Inks Pact with Isis and CHDI for Protein Markers for Huntington's Disease Premium Feb 21, 2013 Isis, CHDI to Use KineMed Biomarker Platform in Huntington's Disease Effort Premium Dec 14, 2012 Myriad RBM Collaborating with Sanofi on Protein Biomarkers for Diabetes Diagnosis, Drug Response Premium Jun 27, 2012 KineMed Receives $1.2M from Michael J. Fox Foundation for Parkinson's Biomarkers Jun 18, 2012 KineMed, GSK Partner on Biomarker Discovery Deal May 15, 2012 KineMed, CHDI Foundation Collaborate on Huntington's Disease Research Feb 3, 2012 In Brief This Week: Affymetrix; PerkinElmer; Waters; KineMed, Pfizer; FDA Feb 3, 2012 KineMed Inks Deal with Pfizer to Use Dynamic Proteomics Platform in Diabetes Drug Development Premium Jun 3, 2011 Protein Biomarkers for Alzheimer's Predicted to Represent Cumulative $9B Market Over Next Decade Premium Mar 11, 2011 KineMed, Bristol-Myers Squibb Extend Collaboration on Alzheimer's Biomarkers Premium Mar 9, 2011 KineMed, Bristol-Myers Squibb Extend Collaboration Covering Alzheimer's Disease Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.